HIV-1-infection Clinical Trials in San Francisco, California

5 studies are recruiting for hiv-1-infection in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Safety Study of MucoCept-CVN

   MucoCept-CVN uses a Lactobacillus strain native to the human vagina that is modified into a live biotherapeutic product (LBP) that continuously expresses a potent anti-HIV drug. If research shows that MucoCept-CVN is safe and effective, it could become a self-renewing, female-initiated prevention p…

   Stage

   Phase 1

   Ages

   18 to 45

   Site

   UCSF Zuckerberg San Francisco General Hospital, San Francisco, California

   Run by

   Craig Cohen, MD, MPH

   See if you can join NCT07181486 on ClinicalTrials.gov

2. A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

   The study will have two parts: Part A and Part B. In Part A, the goal of the study is to compare the effectiveness of switching to the study drugs GS-3242 plus Lenacapavir (LEN) versus continuing Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF)), in virologically suppressed peopl…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Optimus Medical Group, San Francisco, California

   Locations

   55 in total

   Run by

   Gilead Sciences

   See if you can join NCT07645287 on ClinicalTrials.gov

3. PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)

   This is a single center exploratory imaging study involving one intravenous microdose of 89Zr-DFO-VRC01 followed by whole-body PET-MR imaging in HIV infected individuals and healthy volunteers. Imaging data will be obtained from up to four static PE-MR images in order to determine dosimetry and tem…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   University of California, San Francisco, San Francisco, California

   Run by

   University of California, San Francisco

   See if you can join NCT03729752 on ClinicalTrials.gov

4. Observational PIC Destination Cohort

   This study is being done to see if people who control HIV without antiretroviral therapy (ART) after receiving an intervention can remain off ART safely. The information collected in this study is also being used to try to understand how people control HIV without ART after receiving an interventio…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of California, San Francisco HIV/AIDS CRS (801), San Francisco, California

   Locations

   4 in total

   Run by

   Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

   See if you can join NCT05985642 on ClinicalTrials.gov

5. PrEPsmart 2-1-1 Pilot

   This is a pilot study to assess the feasibility, acceptability, and preliminary effectiveness of pre-exposure prophylaxis (PrEP)smart among cisgender sexual minority males (SMM) taking on-demand PrEP over a 6-month period. Upon project completion, the investigators will have developed a highly inno…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Bridge HIV, San Francisco Department of Public Health, San Francisco, California

   Run by

   Public Health Foundation Enterprises, Inc.

   See if you can join NCT06631365 on ClinicalTrials.gov